JP Patent

JP5687631B2 — Ｈｃｖのマクロ環状プロテアーゼ阻害剤を製造するための方法および中間体

Assigned to Janssen Pharmaceuticals Inc · Expires 2015-03-18 · 11y expired

What this patent protects

Patent listed against simeprevir-sodium.

Drugs covered by this patent

simeprevir-sodium (SIMEPREVIR SODIUM)

Patent Metadata

Patent number: JP5687631B2
Jurisdiction: JP
Classification: —
Expires: 2015-03-18
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.